Evidence map›Paper›PMID 41403973›Full record

ArticleOcular oncology and pathology2025

Retinocytoma: Clinical and Genetic Characteristics in 16 Pediatric and Adult Cases.

Chloé Widehen, Nathalie Cassoux, Denis Malaise, Isabelle Aerts, François Doz, Marion Gauthier-Villars, Alexandre Matet, Livia Lumbroso-Le Rouic

Abstract readCase Reports
In one paragraph

Article in Ocular oncology and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chloé WidehenUniversité Paris Cité, Paris, France.
Nathalie CassouxUniversité Paris Cité, Paris, France.
Denis MalaiseDepartment of Ocular Oncology, Institut Curie, Paris, France.
Isabelle AertsSIREDO Center (Care, Innovation and Research in pediatric, adolescent and young adults oncology), Institut Curie, Paris, France.
François DozUniversité Paris Cité, Paris, France.
Marion Gauthier-VillarsDepartment of Medical Genetics, Institut Curie, Paris, France.
Alexandre MatetUniversité Paris Cité, Paris, France.
Livia Lumbroso-Le RouicDepartment of Ocular Oncology, Institut Curie, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Retinocytomas are rare benign intraocular tumors that may mimic spontaneously regressed retinoblastoma (Rb). Materials and Methods: This was a retrospective monocentric study of patients with retinocytoma in a French tertiary ocular oncology center, with an inclusion period from January 1999 to January 2024. Results: Sixteen patients with retinocytoma were identified, and 1,351 Rbs were diagnosed during the same 25-year period. Age at diagnosis ranged from 11 months to 75 years (mean 28.1 years). Thirteen cases were asymptomatic, while three presented with floaters, decreased visual acuity, or strabismus. Clinical presentation was a whitish or grayish retinal tumor with a translucent (87%) and/or fragmented appearance (76%) at diagnosis. A proportion of lesions were surrounded by atrophy (52%) and/or pigmentation (30%). Eleven patients had unilateral retinocytoma (one of which was multifocal), and five had bilateral lesions. Eight patients had a known family history of Rb. Patients were followed regularly and underwent genetic counseling. The eight patients with a family history had a germline pathogenic variation of the Conclusion: The presentation of retinocytoma is most often asymptomatic. Thus, diagnosis may be delayed to far later ages than expected with Rb. Retinocytoma may be associated with germline pathogenic variants of the

Indexed as

RetinaRetinoblastomaRetinocytomaRetinomaTumor

Identifiers

PMID41403973
PMCPMC12705113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.